Shigella test kits help detect the presence of shigella bacteria, which causes shigellosis or bacillary dysentery. Shigellosis infection causes diarrhea, fever and stomach cramps and is highly contagious. Rapid diagnosis of shigellosis is important to provide timely treatment and control the spread of infection. Shigella test kits offer fast and reliable detection of shigella bacteria with high sensitivity and specificity. The global Shigella Test Kit Market is estimated to be valued at US$ 106.4 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends: The rising prevalence of shigellosis infections globally is a major factor driving the demand for shigella test kits. According to the World Health Organization (WHO), there are over 164 million cases of shigellosis reported annually worldwide, causing around 69,000 deaths. Young children in developing countries are particularly at high risk of contracting shigellosis due to poor sanitation and hygiene conditions. Rapid diagnosis of shigella infections is crucial for effective treatment and control. Shigella test kits enable prompt diagnosis and are widely adopted to test patients presenting with diarrhea symptoms. The development of new rapid shigella test kits with improved sensitivity and turnaround time further boosts their demand.
SWOT Analysis
Strength: Shigella test kits provide accurate and timely diagnosis of Shigellosis infection. Detecting the presence of Shigella bacteria allows physicians to provide appropriate antibiotic treatment.
Weakness: The culture-based methods for detecting Shigella require 2-7 days for results. Rapid tests have lower sensitivity compared to culture-based methods.
Opportunity: Increasing incidence of foodborne and waterborne diseases worldwide presents an opportunity. Rising awareness about sanitation and hygiene in developing nations boosts market growth.
Threats: stringent regulations for new product approvals may delay market entry. Developing alternative diagnostic methods poses competition.
Key Takeaways
The global Shigella test kit market is expected to witness high growth over the forecast period of 2023 to 2030. The market size is projected to reach US$ 106.4 Mn by 2024, growing at a CAGR of 5.9% through 2030.
Regional analysis: North America currently dominates the market, owing to rising cases of food poisoning. Asia Pacific is expected to grow at the fastest pace due to improving healthcare infrastructure and growing focus on water quality monitoring in countries like India and China.
Key players operating in the Shigella test kit market are Thermo Fisher Scientific Inc., Meridian Bioscience Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Creative Diagnostics, Hardy Diagnostics, Luminex Corporation, DiaSorin S.p.A., Sekisui Diagnostics LLC, BioMérieux SA, MP Biomedicals LLC, Coris BioConcept, Alere Inc., Fujirebio Diagnostics Inc., and CTK Biotech Inc. These players are focusing on new product launches and partnerships to strengthen their market position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it